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Summary. RON is a transmembrane receptor tyrosine 
kinase that mediates biological activities of Macrophage 
Stimulating Protein (MSP). MSP is a multifunctional 
factor regulating cell adhesion, motility, growth and 
survival. MSP binding to RON causes receptor tyrosine 
phosphorylation leading to up-regulation of RON 
catalytic activity and subsequent activation of 
downstream signaling molecules. Recent studies show 
that RON is spatially and functionally associated with 
other transmembrane molecules including adhesion 
receptors integrins and cadherins, and cytokine and 
growth factor receptors IL-3 Bc, EPOR and MET. For 
example, MSP-induced cell shape change is mediated 
via RON-activated IL-3 Bc receptor. Activation 
of integrins causes MSP-independent RON 
phosphorylation, and the integrin/RON collaboration 
regulates cell survival. Thus, RON can be activated 
without MSP by ligand stimulation of RON-associated 
receptors, and MSP-activated RON can cause ligand- 
independent activation of RON-associated receptors. As 
a result of the receptor cross-activation RON-specific 
pathways become a part of a signal transduction network 
of other receptors, and conversely signaling pathways 
activated by other receptors can be used by RON. This 
receptor collaboration extends the spectrum of cellular 
responses generated by MSP and by putative ligands of 
RON-associated receptors. However signaling pathways 
involved in the receptor cross-talk and underlying 
activation mechanisms remain to be investigated. The 
purpose of this review is to summarize data and to 
discuss a role of cross-talk between RON and other 
transmembrane receptors. 
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lntroduction 
RON (Receptuer d 7 0 r i g i n e  Nantaise) is  a 
transmembrane receptor tyrosine kinase (RTK) 
belonging to the MET RTK family. The RON gene was 
cloned from human keratinocytes (Ronsin et al., 1993), 
and the mouse homologue, known as STK (Stem cell 
derived Tyrosine Kinase), was cloned from mouse 
hematopoietic stem cells (Iwama et al., 1994). The RON 
gene encodes a 190 kDa protein, which is expressed on 
the cell surface a s  a disulfide-linked heterodimer 
comprising 40 kDa a and 150 kDa f3 chains (Angeloni et 
al., 2000). Single chain 190 kDa pro-RON has a basic 
amino acid site KRRRR, intracellular proteolytic 
cleavage of which converts pro-RON into the mature, 
two chain heterodimeric receptor (Gaudino et al., 1994). 
The a chain of RON is located in the extracellular part 
of the receptor, whereas the B chain has extracellular, 
transmembrane and cytoplasmic domains (Fig. 1). The 
extracellular part of RON binds MSP; the cytoplasmic 
part of RON has an intrinsic tyrosine kinase activity, 
which is up-regulated by MSP binding to RON (Gaudino 
et al., 1994). 
The ligand for RON is Macrophage Stimulating 
Protein (MSP) (Wang et al., 1994), also known as  
Hepatocyte Growth Factor-like protein (HGFL). MSP 
was discovered as a serum factor that regulates the 
motility of macrophages (Leonard and Skeel, 1976). 
Recent investigations have shown that the RON is 
expressed on various cell types including macrophages 
(Iwama et al., 1995), osteoclasts (Kurihara et al., 1996), 
epithelial (Wang et al., 1996a) and hematopoietic cells, 
such as erythroid and myeloid progenitor cells (Iwama et 
al., 1996) and bone marrow megakaryocytes (Banu et 
al., 1996). Interaction of MSP with RON causes receptor 
tyrosine phosphorylation and activation, a key event in 
signal transduction from cell surface to cell interior 
(Leonard and Danilkovitch, 2000). 
Signal ing pathways activated by MSPIRON 
interaction mediate cell adhesion, motility, growth and 
survival (Wang et al., 1996a,b; Danilkovitch et al., 1999, 
2000; Danilkovitch and Leonard, 1999; Leonard and 
Danilkovitch, 2000). Recent investigations have shown 
RON cross-talk with other receptors 
that RON kinase activity and RON-activated signaling 
pathways can be regulated through other receptors by 
MSP-independent mechanisms. RON can be a functional 
part of other receptor complexes activated by stimuli that 
do not directly interact with RON, and RON can 
transduce signals and regulate cellular responses induced 
by these stimuli. On the other hand, some biological 
activities induced by MSPIRON interaction are mediated 
by activation of other receptors. 
The cross-talk between RON and other receptors 
generates additional signal diversity, resulting in a wide 
spectrum of cellular biological responses that regulate 
normal cell functional activity as  well as  steps in 
oncogenic cell transformation. 
RON and integrlns 
Integrins are cell surface receptors that mediate cell 
adhesion to extracellular matrix proteins (ECM). 
Integrins are heterodimers consisting of non-covalently 
linked transmembrane a and B chains (Hynes, 1992). 
IntegrinJECM-mediated adhesion activates intracellular 
signaling pathways, which in addition to cell 
adhesiveness also regulate cell growth and survival 
(Hanks and Polte, 1997; Kumar, 1998; Giancotti and 
Ruoslahti, 1999). These signaling pathways include a 
number of intracellular kinases and phosphatases such as 
Foca1 Adhesion kinase (FAK), c-Src, MAPK, 
phosphatidylinositol-3 kinase (PI-3 kinase) and 
phosphatase SHP-2 (Cary et al., 1999). Integrins can 
physically associate and functionally cooperate with 
other receptors including growth factor RTKs (Juliano, 
1996; Miyamoto et al., 1996; Sundberg and Rubin, 
ühdMdlnk.d 
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Flg. l. Schematic representation of immature (intracellular) and mature 
(expressed on cell membrane) RON. RON is synthesized as a 190 kDa 
single chain protein. It has a basic amino acid site KRRRR (amino acid 
residues 305309, indicated by the dosed arrow), proteolytic cleavage 
of which inside the endoplasmic reticulum converts single chain 
immature RON into al3 chain heterodimeric mature RON. The black box 
represents the RON transmembrane domain (amino acid residues 958- 
982). The open box represents the kinase domain (amino acid residues 
1089-1352). The S-S symbol shows disutiide bridges between a and B 
chains of RON. The number and the location of these bonds are still 
unknown. 
1996; Wang et al., 1996; Porter and Hogg, 1998; Soldi et 
al., 1999). 
We have shown by co-immunoprecipitation that 
RON is  physically associated with the B chain of 
integrins (Danilkovitch et al., 1999). Plating of RON- 
expressing epithelial cells on ECM causes ligand- 
independent RON tyrosine phosphorylation and kinase 
activation (Danilkovitch-Miagkova et al., 2000). These 
experimental data show that RON can be tyrosine 
phosphorylated and activated in the absence of its ligand 
MSP via ECMfintegrin-dependent adhesion. ECM- 
dependent RON activation is a multi-step process that 
requires both RON and c-Src kinase activities. Because 
RON is associated with B 1  integrin (Danilkovitch et al., 
1999), ECM-induced integrin aggregation may lead to 
RON oligomerization and transphosphorylation by RON 
kinase. This autophosphorylated RON becomes a target 
for c-Src activated by ECMJintegrin dependent adhesion, 
which results in the phosphorylation of additional 
tyrosines on RON (Danilkovitch-Miagkova et al., 2000). 
When MSP is added to cells plated on ECM, the 
resulting kinase activation and phosphorylation of RON 
is greater than the levels obsewed for cells on ECM 
done or for cells stimulated by MSP in suspension. 
In light of these results and data from the literature, 
we can identify candidate tyrosines on RON that are 
phosphorylated in response to MSP or to plating on 
ECM. Because phosphorylation of tyrosines Y1238 and 
Y1239 is essential for up-regulation of RON catalytic 
activity (Gaudino et al., 1994; Longati et al., 1994; 
Iwama et al., 1996), we suggest that these tyrosines are 
phosphorylated by either the ECM-dependent 
mechanism or by MSP. Additional evidence for their 
role in response to plating is the fact that ECM does not 
trigger tyrosine phosphorylation of kinase dead RON 
(Danilkovitch-Miagkova et al., 2000) indicating that 
ECM induces autophosphorylation of Y1238N1239 in 
RON. 
Once activated, RON kinase can phosphorylate 
tyrosines Y1353 and Y1360 representing the RON C- 
terminal multifunctional docking site for downstream 
signaling molecules (Ponzetto et al., 1994; Iwama et al., 
1996). Thus, either MSP or ECM can trigger 
Y1238N1239 and Y1353N1360 autophosphorylation in 
RON. In addition to these common target tyrosines, 
there are additional phosphorylation sites that are 
specific for one or the other stirnulus. An MSP-specific 
RON tyrosine is  postulated because of the 
phosphorylation increment o b s e ~ e d  when MSP is added 
to cells plated on ECM. On the other hand, ECM- 
specific RON tyrosine phosphorylation occurs because 
auto-phosphorylated RON from plated cells (but not 
from MSP-stimulated cells in suspension) is a target for 
c-Src kinase, which is activated via a FAK pathway in 
response to ECMIintegrin interaction (Hanks and Polte, 
1997; Giancotti and Ruoslahti, 1999). 
What are c-Src phosphorylation sites in RON? 
Although those sites have been not mapped, we can 
suggest potential c-Src phosphorylation sites in RON on 
RON cross-talk with other receptors 
the basis of tyrosine motifs of the c-Src-dependent 
phosphorylation sites that have been identified in the 
EGFR (Gotoh et al., 1992; Sato et al., 1995; Stover et 
al., 1995; Biscardi et al., 1999; Tice et al., 1999). The 
three potential sites (Y1198, Y1288, Y1317) and their 
motifs are listed in Table 1. 
How can RON be involved in ECWintegrin-induced 
signal transduction? Just as there are common and 
unique RON phosphorylation sites depending on the 
stimulus, the same applies to resultant signal 
transduction. Thus, either MSP or ECM plating should 
generate docking sites on RON for signaling proteins 
with SH2 or PTB domains. Likewise, either stimulus 
increases RON kinase catalytic activity, which results in 
phosphorylation of RON substrates involved in signal 
transduction. On the other hand, the data that c-Src can 
phosphorylate RON from cells stimulated by ECM, but 
not by MSP (Danilkovitch-Miagkova et al., 2000), can 
be the basis for a signaling pathway that is unique to the 
ECM stimulus. 
A possible signal in this pathway is Stat3. Analysis 
of tyrosine motifs in RON reveals that Y1101 has a 
motif Y-1-D-Q (Table l ) ,  which matches a consensus 
motif Y-X-X-Q for Stat3 transcriptional factor binding 
(Coffer and Kruijer, 1995; Stahl et al., 1995). MSP 
stimulation does not cause Stat3 interaction with 
the RON in epithelial cells, but Stat3 i s  co- 
immunoprecipitated with ECM-activated RON 
(unpublished data). It suggests the hypothesis that 
Y1101 might represent one of the tyrosines that is 
responsible for specificity of ECM-initiated RON 
signaling. 
It is also possible for signaling to depend on the 
combination of MSP and ECM stimuli. For example, we 
have shown that MSP promotes survival of epithelial 
cells in serum-free medium via two independent 
pathways, one involving PI3-kinase and the other 
involving MAPK. If the PI3-kinase pathway is blocked, 
MSP prevents apoptosis of adherent cells, but not ceils 
in suspension. Although MSP activates MAPK of either 
suspended or adherent cells, translocation of MAPK 
from cytoplasm to nucleus occurs only in the adherent 
cells @anilkovitch et al., 2000). Thus, the combination 
of ECM and MSP may activate pathways that are 
activated by neither MSP nor by adhesion done. 
Additional signaling diversity might be generated by 
spatial availability of signaling molecules and RON 
substrates due to differences in MSP or ECM-induced 
RON receptor aggregation. For example, it has been 
shown that ECM can increase association between 
tyrosine specific phosphatase SHP-2 and BPDGFR due 
to enhancement in the availability of SHP-2 to the 
PDGFR @eMali et al., 1999). Another example is that 
cross-linking of integrins by ECM not only activates the 
EGFR, but also results in the spatial juxtaposition of Shc 
with activated EGFR (Moro et al., 1998; Kuwada and Li, 
2000). ECM-induced integrin aggregation can also make 
available molecules including SHP-2 for association 
Table 1. Functional role of tyrosine residues in RON cytoplasmic domain. 
N TYROSINE SEQUENCE FUNCTIONAL ROLE 
POSlTlON FROM 
IN RON -1 TO +3 
L-YS-G-S" Unknown 
D-Y-R-S-G Unknown 
V-Y-H-G-E Unknown 
E-Y-1-D-Q Potential Stat3 binding site, the sequence matches Y-X-X-Q consensus moti (Stahl et al., 1995) 
P-Y-M-C-H Unknown 
E-Y-L-A-E Potential c-Src phosphorylation site, clos8st homology to Y845 (E-Y-H-A-G) on the EGFR and Y416 (E-Y- 
T-A-R) in c-Src (Sto et al., 1995; Biscardi et al., 1999; Kmiecik and Shalloway, 1987; Piwnica-Worms et al., 
1987) 
E-Y-Y-S-V Autophosphorylation site, autophosphorylated in response to MSP and ECM, can be phosphorylated 
byacüvated MET (Gaudino et al., 1994; Longati et al, 1994; lwama et al., 1996; Follenzi et al., 2000) 
Y-Y-S-V-Q Autophosphorylation site, autophosphorylated in response to MSP and ECM, can be phosphorylated 
by activated MET (Gaudino et al., 1994; Longati et al, 1994; lwama et al., 1996; Follenzi et al., 2000) 
T-Y-R-F-T Unknown 
P-Y-R-H-I Potential c-Src phosphorylation site, closest homology to Y891 (P-Y-D-G-1) in the EGFR (Stover et al, 1995) 
E-Y-C-P-D Unknown 
L-Y-Q-V-M Potential c-Src phosphorylation site, closest hornology to Y920 (V-Y-M-1-M) in the EGFR (Stover et al, 
1995); R mediates oncogenic properties of M1254T RON mutant (Santoro et al., 2000) 
H-Y-V-Q-L Autophosphorylation site, phosphorylation can be induced by MSP, ECM and HGF, a multifunctional 
docking site (Gaudino et al., 1994; Ponzetto et al., 1994; lwama et al., 1996; Follend et al., 2000) 
14. Y1360 T-Y-H-N-L Autophosphorylation site, phosphorylation can be induced by MSP, ECM and HGF, a mulüfunctional 
docking site (Gaudino et al., 1994; Ponzetto et al., 1994; lwama et al., 1996; Follenzi et al., 2000) 
*: one letter code 
RON cross-talk with other receptors 
with RON. SHP-2 has been found in association with 
RON in adherent cells stimulated by MSP (unpublished 
data). It is not known whether the RONJSHP-2 
association is direct, but there are severa1 tyrosines in 
RON, including the C-terminal multifunctional docking 
site, that match the consensus motif Y-X-X-L/V/I 
representing a potential binding site for SHP-2 (Eck et 
al., 1996). 
RON and MET receptor 
RON and MET belong to the same RTK family and 
share many common structural features: i) mature 
receptors are disulfide-linked heterodimers; ii) two 
tyrosine residues in the kinase domain activation loop of 
the í3 chain upregulate the receptor kinase activity; iii) 
two C-terminal tyrosine residues represent a 
multifunctional docking site that mediates interactions 
with multiple SH2-domain containing signaling 
molecules. Interaction of MSP and HGF with 
their receptors is  believed to induce receptor 
homodimerization, which causes receptor 
transphosphorylation and activation (Ullrich and 
Schlessinger, 1990; Heldin, 1995). 
A recent investigation shows that activated MET can 
transphosphorylate RON, and vice versa. Either HGF 
stimulation of cells co-expressing wild type MET and 
kinase inactive RON or MSP stimulation of cells co- 
expressing wild type RON and kinase inactive MET 
caused tyrosine phosphorylation of both MET and RON 
(Follenzi et al., 2000). Thus, tyrosine phosphorylation of 
the inactive receptor occurred when cells were 
stimulated with the ligand for the active receptor. 
Transphosphorylation occurred in MET or RON even 
with receptor mutants lacking the C-terminal docking 
sites for signal transducing molecules. This suggests that 
receptor phosphorylation by the non-corresponding 
ligand is  not mediated by downstream signaling 
molecules. Mapping of transphosphorylated tyrosines 
showed that catalytic site tyrosines (Y1234N1235 in 
Met and Y12381Y1239 in RON) and the C-terminal 
docking site tyrosines (Y1349JY1356 in MET and 
Y1353/Y1360 in RON) are the major trans- 
phosphorylation sites (Follenzi et al., 2000). 
We have observed tyrosine phosphorylation of 
kinase-dead RON in RON-transfected MDCK cells 
expressing endogenous MET receptor. In these cells 
transphosphorylation of kinase-dead RON occurred 
when MET was activated by cell plating on an ECM- 
coated surface (unpublished data). This shows that in 
addition to HGF other stimuli causing MET activation 
can induce ligand-independent RON phosphorylation. 
Homo- and heterodimers between RON and MET 
have been detected on the cell surface in the absence of 
ligand stimulation (Follenzi et al., 2000). This indicates 
that the receptors are co-localized, and because of spatial 
proximity one receptor may transphosphorylate another 
one after activation by the appropriate ligand. 
Heterodimers between RON or MET and receptors in 
different families (ErbB1, ErbB2 or TrkA) have been not 
detected. It correlated with the absence of 
transphosphorylation between RON or MET and these 
other receptors (Follenzi et al., 2000). Thus, the 
transphosphorylation in this experimental system was 
confined to the receptor subfamily members. 
In contrast to these results, cross-talk between the 
EGFR and MET has been described. In rat epithelial 
cells as well in some human tumor cell lines expression 
of TGFa and its receptor, EGFR cause constitutive 
ligand-independent tyrosine phosphorylation of MET. 
This cross-talk between MET and EFGR may have 
significant implications for altered growth control in 
tumorigenesis (Jo et al., 2000). Stimulation of cells with 
EGF may cause ligand-independent tyrosine 
phosphorylation of PDGFR followed by activation of 
P13-kinase (Habib et al., 1998). P13-kinase is the only 
kinase found to be associated with the PDGFR in cells 
exposed to EGF. Therefore, EGFR-mediated tyrosine 
phosphorylation of the PDGFR could have a number of 
functional consequences that are dependent on PI3- 
kinase activity (Habib et al., 1998). 
These examples show that heterodimerization 
between receptor tyrosine kinases from different 
subfamilies may be more widespread than previously 
believed. Although heterodimerization between RON 
and other receptor tyrosine kinases from different 
families has not been shown, it may occur and have 
functional import. 
What is the possible physiological role of cross-talk 
between RON and MET? It may lead to more efficient 
signaling initiated by HGF or MSP. For example, 
formation of an ErbB2lErbB3 heterodimer results in 
more efficient signaling, because ErbB2 itself induces 
weak activation of P13-kinase, whereas co-expression 
with ErbB3 leads to strong activation of P13-kinase 
(Wallasch et al., 1995). A similar effect on P13-kinase 
activation has been observed in cells expressing the 
EGFRIPDFGR heterodimer (Habib et al., 1998). 
Expression of various members of the EGFR family 
and cross-talk between the members of the EGFR family 
plays a leading role in tumor progression (Kim and 
Muller, 1999). RON and MET are overexpressed in 
tumor cells (Bardelli et al., 1997; Maggiora et al., 1998; 
Willett et al., 1998; Wallenius et al., 2000), and cross- 
talk between RON and MET could lead to sustained 
signaling that might be critica1 for tumorigenesis. 
RON and interleukin-3 receptor (IL-3R) 
RON is expressed on various subsets of 
hematopoietic cells. Its ligand, MSP, is a multifunctional 
factor for hematopoietic cells. It may promote or inhibit 
proliferation or induce cell death (Iwama et al., 1996), or 
cause megakaryocyte cell differentiation (Broxmeyer et 
al., 1996). Recently, it has been found that MSPIRON 
interaction causes morphological changes in an IL-3- 
dependent cell line (Mera et al., 1999). RON is 
associated with the IL-3 receptor Bc chain in these cells. 
RON cross-talk with other receptors 
Cell stimulation either by MSP or IL-3 induces a similar 
pattern of protein tyrosine phosphorylation, and causes 
morphological changes in cells. It appears that MSP- 
activated RON can directly phosphorylate the IL-3 
receptor Bc chain, followed by association of tyrosine 
phosphorylated IL-3Bc with intracellular pp90 protein. 
This pp90 protein seems to be involved in both IL-3 and 
MSP-induced cell shape changes (Mera et al., 1999). 
IL3, IL-5 and GM-CSF belong to the same cytokine 
family, and their receptors have a shared receptor 
subunit named the common B chain (Bc) (de Groot et al., 
1998). It is possible that RON will cause tyrosine 
phosphorylation of Bc chain of IL-5 and GM-CSF to 
transduce signals responsible for MSP-induced cell 
shape changes, if RON and these receptors are both on 
the cell membrane. Thus, in addition to IL3R, IL-5 and 
GM-CSF receptors are potential RON partners in MSP- 
activated signaling. 
RON and the erythropoietin receptor (EPOR) 
Erythropoietin (EPO) is the ligand for the EPOR, a 
transmembrane protein that i s  essential for  the 
development and differentiation of committed erythroid 
progenitor cells (Wojchowski e t  al., 1999). The  
interaction between EPO and its receptor initiates signal 
transduction pathways leading to cell proliferation and 
consequent increase in red cell mass (Wojchowski et al., 
1999). The EPOR plays an important role in the 
development of hematopoietic disorders, including 
erythroleukemia (Michiels, 1993; McMullin and Percy, 
1999). 
Erythroleukemia i s  a malignant disease, 
characterized by large numbers of dyserythropoietic 
erythroblasts in the peripheral blood and bone marrow, 
splenomegaly and hepatomegaly due to extramedullary 
dysplastic hematopoiesis, and clinical manifestations of 
severe anemia (Michiels, 1993; Mazzella et al., 2000). 
There is an experimental model in which infection of 
mice with Friend virus causes erythroleukemia. A 
number of host genes affect susceptibility to Friend 
disease (Kumar et al., 1978; Shibuya and Mak, 1982; 
Best et al., 1996). Recently it has been discovered that 
the FV2 (Friend virus susceptibility 2) locus, which 
mediates susceptibility to Friend virus-induced 
erythroleukemia in mice (Lilly, 1970), encodes a 
truncated form of RON (Persons et al., 1999). This 
truncated form of RON might be involved in 
erythroleukemia development or progression. 
In cells that were co-transfected with RON, EPOR 
and p55 Friend virus protein cDNAs, these proteins were 
co-immunoprecipitated as a complex (Herley et al., 
1999). The association of EPOR with either truncated or 
full sized RON has been identified. Co-expression of 
RON and EPOR resulted in EPOR tyrosine 
phosphorylation. These results suggest that RON is a 
part of EPOR complex. Functional association between 
EPOR and IL3R, or EPOR and c-Kit receptor has been 
shown previously (Wojchowski e t  al., 1999). For 
example, cell stimulation by Stem Cell Factor (SCF), the 
c-Kit receptor ligand, induces EPO-independent EPOR 
tyrosine phosphorylation, and this cross-talk between c- 
Kit and EPOR is  important for  erythroid cell 
proliferation (Wu et al., 1995). Thus, we can speculate 
that MSP-stimulated RON might cause EPOR tyrosine 
phosphorylation and signaling, or EPO-activated EPOR 
through associated kinases (for example, Jak2 or c-Src- 
related kinases) might cause RON phosphorylation and 
activation. RON/EPOR cross-talk might be crucial for 
regulation of normal erythropoiesis as well as  in 
erythroleukemia development. 
RON and cadherinslcatenins 
Activating mutations in growth factor RTKs may 
result in oncogenic cell transformation and tumor 
development. A number of human neoplastic syndromes 
are associated with activating point mutations in a highly 
conserved region of the tyrosine domains of Kit, Ret and 
Met receptors (Nagata et al., 1995; Santoro et al., 1995; 
Tsujimura, 1996; Jeffers et al., 1997; Schmidt et al., 
1997). Although RON has not yet been implicated in 
human neoplasia, experimental mutations in the RON 
kinase domain (D1232V -"Kit" type and M1254T 
-"Retl' type mutations) result in a tumorigenic 
phenotype (Santoro et al., 1998). The investigation of 
signaling pathways activated by these RON mutants 
show that 8-catenin is  constitutively tyrosine 
phosphorylated in cells expressing mutant RON. The 
increase in B-catenin was associated with an increase in 
its target oncogene products, c-myc and cyclins A and 
D1 (unpublished data). Because increased B-catenin 
occurs in many human cancers (Korinek et al., 1997; 
Morin et al., 1997; Rubinfeld et al., 1997; Chan et al., 
1999; Morin, 1999; Polakis, 1999; Satoh et al., 2000), 
accumulated 6-catenin initiated by oncogenic RON 
mutants may be implicated in tumor formation. We also 
found that both wild type and mutated RON are co- 
immunoprecipitated with E-cadherin and B-catenin 
(unpublished data). Although we could not detect 
tyrosine phosphorylation of cadherinlcatenin by RON 
wild type, the association between RON and cadherins 
indicates possible receptor cross-talk playing an 
important role in regulation of cadherinlcatenin- and 
RON-dependent cell functions. 
Cadherins are transmembrane receptors that are 
involved in regulation of cell-cell mediated adhesion 
(Gumbiner, 1996,2000). B-catenin (Drosophila homolog 
Armadillo) is a multifunctional intracellular protein 
discovered as a component of adherent junctions (Ozawa 
et al., 1989). B-catenin associated with E-cadherin and 
a-catenin at the plasma membrane regulates cell  
adhesion, whereas cytoplasmic B-catenin is involved in 
signal transduction and activation of gene expression 
(Ben-Ze'ev and Geiger, 1998; Bullions and Levine, 
1998; Bienz, 1999). Association with and regulation of 
cadherinlcatenin tyrosine phosphorylation via growth 
factor RTKs has been shown for MET and EGFR 
RON cross-talk with other receptors 
Table 2. Effects of ligand-activated receptors on the RON. 
RECEPTOR ASSOCIATED LIGAND EFFECTS OF LIGAND-ACTIVATED BlOLOGlCAL EFFECTS 
WlTH RON RECEPTORS ON RON 
lntegrin (Bl integrin) ECM Tyrosine phosphorylation and activation; Sustained activation oí signaling pathways? 
increases effects of MSP Protecüon from apoptosis via the MAPK pathway? 
MET HGF Tyrosine phosphorylation and activation Sustained activation of signaling pathways 
Cadherin (E-Cadherin) Cadherin Unknown Unknown 
11-3 Bc 11-3 No effect No effect 
EPOR EPO Unknown Unknown 
POTENTIAL RON LIGAND POTENTIAL EFFECTS OF LIGAND- POTENTIAL BlOLOGlCAL EFFECTS 
PARTNERS ACTIVATED RECEPTORS ON RON 
- -- - -- 
11-5 Bc 11-5 No effect No effect 
GM-CSF Bc GM-CSF No effect No effect 
Table 3. Effects of MSP-activatd RON on the RON-associated receptors. 
RECEPTOR ASSOCIATED EFFECTS OF MSP-INDUCED RON A C T I V A ~ N  B~OLOGICAL EFFECTS 
WlTH RON ON THE RECEPTOR 
lntegrin (B1 integrin) 
MET 
Cadherin (E-Cadherin) 
11-3 BC 
EPOR 
POTENTIAL RON 
PARTNERS 
IL-5 BC 
GM-CSF BC 
Unknown lncreased integrin-dependent adhesion 
Tyrosine phosphorylation and acüvation Sustained acüvation of signaling pathways 
Tyrosine phosphorylaüon of cadherin and B-catenin* Stabilition oí B-catenin*; lncreased leve1 of c-myc and 
cyclin D I  expression. Oncogenic cell transformation pathway? 
Tyrosine phosphorylation of 11-3 Bc Morphdogical changes 
Tyrosine phosphorylation of EPOR Unknown 
POTENTIAL EFFECTS OF MSP-INDUCED POTENTIAL BlOLOGlCAL EFFECTS 
RON ACTlVATlON ON THE RECEPTOR 
Tyrosine phosphorylation of 11-5 Bc Morphologicai changes 
Tyrosine phosphorylation of GM-CSF 0c Morphological changes 
*: effects of constitutively active mutated RON M1254 or D1232V 
(Hoschuetzky et al., 1994; Kanai et al., 1995; Hiscox 
and Jiang, 1999a,b; Muller et al., 1999). Tyrosine 
phosphorylation of cadherin and catenin regulates their 
association/dissociation, playing an important role in 
regulation of cell adhesion and signaling (Daniel and 
Reynolds, 1997; Roura et al., 1999). RON wild type may 
be a component of cadherin receptor complex involved 
in regulation of cell-mediated adhesion and signaling, 
whereas oncogenic RON mutants can utilize the 
cadherinlcatenin pathway to cause tumorigenic cell 
transformation. 
Conclusion 
RON is spatially and functionally associated with 
other membrane receptors (data are summarized in 
Tables 2, 3). Signaling mediated by RON or other 
receptors is not a direct linear pathway from the cell 
surface. Receptor cross-talk generates diversity of 
cellular responses to a single ligand. RON as a part of 
multi-receptor complexes is important for regulation of a 
number of cell functions including adhesion and 
migration, growth and survival. The data summarized in 
this review show the biological significance of RON 
signaling networks, and describe directions for future 
investigations. 
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